Vaxart Inc (VXRT)
0.749
+0.05
(+6.91%)
USD |
NASDAQ |
May 02, 16:00
0.7468
0.00 (0.00%)
After-Hours: 20:00
Vaxart Cash from Operations (Quarterly): -13.52M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -13.52M |
| September 30, 2023 | -15.00M |
| June 30, 2023 | -17.47M |
| March 31, 2023 | -24.46M |
| December 31, 2022 | -29.15M |
| September 30, 2022 | -14.62M |
| June 30, 2022 | -25.90M |
| March 31, 2022 | -25.11M |
| December 31, 2021 | -15.81M |
| September 30, 2021 | -14.27M |
| June 30, 2021 | -13.16M |
| March 31, 2021 | -16.59M |
| December 31, 2020 | -10.77M |
| September 30, 2020 | -9.255M |
| June 30, 2020 | -0.521M |
| March 31, 2020 | -3.208M |
| December 31, 2019 | -3.792M |
| September 30, 2019 | -4.328M |
| June 30, 2019 | -0.317M |
| March 31, 2019 | -4.653M |
| December 31, 2018 | -5.702M |
| September 30, 2018 | -5.358M |
| June 30, 2018 | 7.102M |
| March 31, 2018 | -10.59M |
| December 31, 2017 | -4.70M |
| Date | Value |
|---|---|
| September 30, 2017 | -4.50M |
| June 30, 2017 | 1.20M |
| March 31, 2017 | -11.50M |
| December 31, 2016 | -9.00M |
| September 30, 2016 | -10.70M |
| June 30, 2016 | 1.10M |
| March 31, 2016 | -7.00M |
| December 31, 2015 | -9.10M |
| September 30, 2015 | 0.90M |
| June 30, 2015 | 0.20M |
| March 31, 2015 | 0.80M |
| December 31, 2014 | 1.00M |
| September 30, 2014 | -11.60M |
| June 30, 2014 | 10.60M |
| March 31, 2014 | 0.70M |
| December 31, 2013 | -8.40M |
| September 30, 2013 | -6.20M |
| September 30, 2012 | -1.846M |
| June 30, 2012 | -2.225M |
| March 31, 2012 | -1.515M |
| December 31, 2011 | -0.707M |
| September 30, 2011 | -5.428M |
| June 30, 2011 | -0.428M |
| March 31, 2011 | -8.603M |
| December 31, 2010 | -1.547M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-29.15M
Minimum
Dec 2022
-0.317M
Maximum
Jun 2019
-13.54M
Average
-14.27M
Median
Sep 2021
Cash from Operations (Quarterly) Benchmarks
| Novavax Inc | -176.78M |
| aTyr Pharma Inc | -11.06M |
| Allogene Therapeutics Inc | -53.71M |
| AIM ImmunoTech Inc | -9.758M |
| Protalix BioTherapeutics Inc | 3.595M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 15.10M |
| Cash from Financing (Quarterly) | -0.066M |
| Free Cash Flow | -72.32M |
| Free Cash Flow Per Share (Quarterly) | -0.0946 |
| Free Cash Flow to Equity (Quarterly) | -13.42M |
| Free Cash Flow to Firm (Quarterly) | -13.12M |
| Free Cash Flow Yield | -67.92% |